Avid Bioservices Inc (CDMO)

[biopharm]

Scott Antonia : Peregrine Pharmaceuticals KOL :

Prelude To A Cure: The grand finale to lung cancer

Dr. Lary Robinson: President

Lary Robinson, MD, is one of the nation's most highly recommended thoracic surgeons. Upon completion of his medical degree from Washington University School of Medicine in St. Louis, Missouri, Dr. Robinson continued his education with general and thoracic surgery residencies at Duke University as well as a fellowship in cardiac research and clinical cardiac surgery at St. Thomas' Hospital in London, England. He is currently practicing thoracic Surgical Oncology at Moffitt Cancer Center. He is author of over 120 medical publications, 19 book chapters, and editor of a textbook, most of which involve thoracic oncology. Throughout his years as a medical professional, Dr. Robinson has been directly involved in 8 clinical cancer research programs relating to lung cancer and mesothelioma. Throughout his carer, thousands of patients have been treated successfully with Dr. Robinson's clinical expertise and compassionate care.

Dr. Scott Antonia: Vice President

Scott Antonia, MD, PhD is a Professor of Oncology holding the positions of Co-Leader of the Immunology Program and Chairman of the Thoracic Oncology Department at Moffitt Cancer Center. A Medical Oncologist in the Thoracic Department specializing in lung cancers, Dr. Antonia received basic research training in cellular immunology while participating in a physician scientist training program at the University of Connecticut (1983-1987). Upon completion of medical school and internal medicine training at Yale, he trained with Dr. Richard Flavell (Immunobiology, Yale School of Medicine) during his Medical Oncology fellowship, receiving further research experience in cellular immunology as well as molecular biology (1992-1994). At Moffitt Cancer Center, Dr. Antonia has developed a translational research program utilizing his molecular biology and cellular immunology training in the development of immunotherapeutic strategies for the treatment of cancer patients.

http://www.preludetoacure.com/7.html

Follow on twitter:
Follow @PreludetoaCure1